Ignacio del Arco - Concepedia

Author

Ignacio del Arco

Also Known As

I Del Arco-Herrera, I. del Arco, IGNACIO DEL ARCO, Ignacio Del Arco, Ignacio Del Arco‐Herrera, Ignacio del Arco, Ignacio del Arco-Herrera

Publications

2.7K

Citations

H-Index

Concepts

All Affiliations

Hospital Doctor José Molina Orosa Universidad Complutense de Madrid Scripps Research Institute Instituto de Salud Carlos III Consejo Superior de Investigaciones Científicas

About

Ignacio del Arco is an author at Hospital Doctor José Molina Orosa specializing in medicine, pharmacology, and health sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	815
2	Health Sciences	4	4	560
3	Social Sciences	2	2	83
4	Public Health	1	1	46
5	Allergy	1	1	46

Ignacio del Arco

Publications

2.1K

Citations

H-Index

Page 1

	Year	Citations
A Peripheral Mechanism for CB1 Cannabinoid Receptor-Dependent Modulation of Feeding Raquel Gómez de Heras, Miguel Navarro, Belén Ferrer, Journal of Neuroscience	2002	485
Functional Interaction between Opioid and Cannabinoid Receptors in Drug Self-Administration M. Navarro, M. Rocı́o A. Carrera, Walter Fratta, Journal of Neuroscience Morphine-induced Place PreferenceSubstance UseFunctional InteractionCannabinoidsHealth Sciences	2001	370
Acute administration of the CB1 cannabinoid receptor antagonist SR 141716A induces anxiety-like responses in the rat Miguel Navarro, Elena Hernández de la Torre, Raúl M. Muñoz, Neuroreport	1997	306
CB1 cannabinoid receptor antagonist-induced opiate withdrawal in morphine-dependent rats Miguel Navarro, Julie A. Chowen, M. Rocı́o A. Carrera, Neuroreport	1998	153
Absence of LPA1 Signaling Results in Defective Cortical Development Guillermo Estivill‐Torrús, Pedro Llebrez-Zayas, Elisa Matas-Rico, Cerebral Cortex	2007	145
Cannabinoid CB1 receptor antagonism reduces conditioned reinstatement of ethanol‐seeking behavior in rats Andrea Cippitelli, Ainhoa Bilbao, Anita C. Hansson, European Journal of Neuroscience	2005	141
α-Tocopherol Protects Against Oxidative Stress in the Fragile X Knockout Mouse: an Experimental Therapeutic Approach for the Fmr1 Deficiency Yolanda de Diego‐Otero, Silvana‐Yanina Romero‐Zerbo, Rajaa El Bekay, Neuropsychopharmacology InflammationKnockout MouseRedox SignalingMedicineFmr1 Deficiency	2008	126
Enhanced markers of oxidative stress, altered antioxidants and NADPH‐oxidase activation in brains from Fragile X mental retardation 1‐deficient mice, a pathological model for Fragile X syndrome Rajaa El Bekay, Silvana‐Yanina Romero‐Zerbo, Juan Decara, European Journal of Neuroscience	2007	82
The cannabinoid CB1 receptor antagonist SR141716A (Rimonabant) enhances the metabolic benefits of long-term treatment with oleoylethanolamide in Zucker rats Antonia Serrano, Ignacio del Arco, Francisco Javier Pavón, Neuropharmacology Cannabis UseZucker RatsPsychoactive DrugHealth SciencesFunctional Selectivity	2007	80
Characterization of the acute endocrine actions of (−)-11-hydroxy-Δ8-tetrahydrocannabinol-dimethylheptyl (HU-210), a potent synthetic cannabinoid in rats José Luis Martı́n-Calderón, Raúl M. Muñoz, María Ángeles Villanúa, European Journal of Pharmacology Cannabis UseMolecular PharmacologyAcute Endocrine ActionsPsychoactive DrugHealth Sciences	1998	76

Page 1